Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Becton Dickinson Infusion Therapy Aktiebolag
AB
Active
Org 5560398108
Florettgatan 29 C, 254 67
Helsingborg
Activities of head offices
· NACE 7010
Est. 1940
0 employees
Watchlist
Share
Sweden
/
Companies
/
Activities of head offices
/
Becton Dickinson Infusion Therapy Aktiebolag
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
2M
3M
5M
7M
4M
2021
5M
2022
5M
2023
6M
2024
6M
2025
EBITDA
SEK millions
0M
12M
23M
35M
46M
28M
2021
32M
2022
36M
2023
39M
2024
40M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
4 499
4 956
4 909
5 709
5 616
Staff expenses
—
—
—
—
—
EBITDA
28 334
32 374
35 577
38 520
40 415
Depreciation & amort.
—
—
—
—
—
EBIT
28 334
32 374
35 577
38 520
40 415
Net financials
165
10 496
4 133
8 220
6 596
Profit before tax
28 499
42 870
39 710
46 740
47 011
Tax
−6 116
−8 834
−8 184
−9 684
−9 694
Net profit
22 383
34 036
31 526
37 056
37 317
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
108 751
145 882
181 838
215 156
250 182
Equity
106 923
140 959
172 485
209 541
246 858
Long-term debt
0
0
0
0
0
Short-term debt
1 828
4 923
9 353
5 615
3 324
Total debt
1 828
4 923
9 353
5 615
3 324
Financial ratios
5-year trend
EBITDA margin
719.6%
This company
15.8%
Market median
+4454% vs market
2021
2025
Equity ratio
98.7%
This company
38.2%
Market median
+158% vs market
2021
2025
Return on equity
15.1%
This company
18.4%
Market median
+18% vs market
2021
2025
Net profit margin
664.5%
This company
8.1%
Market median
+8104% vs market
2021
2025
Asset turnover
0.02×
This company
1.12×
Market median
-98% vs market
2021
2025
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-10-01 – 2025-09-30
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-10-01 – 2024-09-30
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-10-01 – 2023-09-30
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-10-01 – 2022-09-30
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-10-01 – 2021-09-30
View
PDF
More on Becton Dickinson Infusion Therapy Aktiebolag
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
